Machinify Principal Software Engineer, Ianiv Schweber unpacks how Machinify applies agentic AI principles to software development to deliver healthcare intelligence solutions that make a real difference for our clients.
Recently, we sat down with Machinify’s Chief Data Scientist, Vijay Bharadwaj, to ask all the important AI questions. Let’s get into it.
In healthcare, complexity is a given. But at Machinify, we believe the real differentiator isn’t just our technology, it’s how we apply it with purpose. That’s why one of our core values, Optimize for Customer Impact, matters so much.
Machinify CEO, David Pierre, sat down with Bloomberg’s Jonathan Palmer to discuss what’s on the horizon for Machinify and payment integrity.
At Machinify, “Think Big” is not just a value we aspire to, it is a way of operating that has defined us for decades.
Coordination of Benefits (COB) is used to establish the order in which a health insurance plan pays claims when an individual has more than one insurance carrier.
Principal Engineer, CJ Silverio, explains how “Asking Why” helps us move forward. One reason? We don’t just take things at face value—we get to the root of the problem.
Earlier this month, in partnership with Fierce Healthcare, Machinify’s Chief Product Officer, Prasanna Ganesan, presented a webinar titled, “A Healthcare Evolution: Modernizing Your Health Plan With an AI Operating System.”
At Machinify, we’re always looking for new ways to bring clarity to complex payment integrity challenges—and pharmacy is no exception. Chris Powers, VP of National Sales, sat down with Derek McMahan, SVP of Pharmacy to answer the industry’s most pressing questions.
At Machinify, we’re using a new class of artificial intelligence—Agentic AI—to fundamentally change clinical data extraction.
In the complex world of healthcare reimbursement and oversight, few acronyms carry as much weight for Medicare Part D payers as PDE—Prescription Drug Event.
To better understand the state of AI applications and adoption amongst payers, Machinify surveyed 100 executives from U.S. health plans.